SCHEMBL19080075

SCHEMBL19080075

c1ccc2c(-c3c4ccccc4c(-c4ccc5cc(-c6cc7oc8c9ccccc9c9ccccc9c8c7c7ccccc67)ccc5c4)c4ccccc34)cccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.38
PRKDC P78527 1/20 0.35
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
ALDH1A1 P00352 4/20 0.33
HSD17B10 Q99714 3/20 0.33
KDM4E B2RXH2 2/20 0.33
CYP1A2 P05177 2/20 0.33
GPR84 Q9NQS5 1/20 0.33
PIM1 P11309 1/20 0.33
CYP2C19 P33261 1/20 0.33
RAB9A P51151 1/20 0.33
ATM Q13315 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
MAPT P10636 2/20 0.33
ARSA P15289 1/20 0.33
CDC25A P30304 1/20 0.33
CDC25C P30307 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079952 0.91 ALOX5 (0.37) ALOX5ALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL19080103 0.91 GPR84 (0.39) ALOX5PRKDCCYP1A1CYP1B1ALDH1A1
SCHEMBL19076452 0.90 ALOX5 (0.42) ALOX5PRKDCCYP1A1CYP1B1ALDH1A1
SCHEMBL19080068 0.90 CYP1A1 (0.35) ALOX5CYP1A1CYP1B1CYP1A2CYP2C19
SCHEMBL19080064 0.89 ABCG2 (0.38) CYP1A1ALDH1A1HSD17B10CYP1A2GPR84
SCHEMBL19080063 0.88 CYP1A1 (0.42) PRKDCCYP1A1CYP1B1ALDH1A1HSD17B10
SCHEMBL19080089 0.88 CYP1A1 (0.36) ALOX5PRKDCCYP1A1CYP1B1ALDH1A1
SCHEMBL19079993 0.87 CYP1A1 (0.37) ALOX5PRKDCCYP1A1CYP1B1ALDH1A1
SCHEMBL19076450 0.87 ALOX5 (0.43) ALOX5PRKDCCYP1A1CYP1B1ALDH1A1
SCHEMBL17931984 0.87 ALOX5 (0.37) ALOX5CYP1A1CYP1B1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ALOX5 1871/4885PRKDC 4792/4885CYP1A1 147/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ALOX5 1871/4885PRKDC 4792/4885CYP1A1 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.